Xu C - Search Results

1

Heptadecanoic acid inhibits cell proliferation in PC‑9 non‑small‑cell lung cancer cells with acquired gefitinib resistance.

Xu C, Wu P, Gao J, Zhang L, Ma T, Ma B, Yang S, Shao G, Yu Y, Huang X, Yang X, Zhang B. Xu C, et al. Oncol Rep. 2019 Jun;41(6):3499-3507. doi: 10.3892/or.2019.7130. Epub 2019 Apr 18. Oncol Rep. 2019. PMID: 31002344

2

miR-526a regulates apoptotic cell growth in human carcinoma cells.

Yang X, Wang C, Xu C, Yan Z, Wei C, Guan K, Ma S, Cao Y, Liu L, Zou D, He X, Zhang B, Ma Q, Zheng Z. Yang X, et al. Among authors: xu c. Mol Cell Biochem. 2015 Sep;407(1-2):69-76. doi: 10.1007/s11010-015-2455-6. Epub 2015 May 23. Mol Cell Biochem. 2015. PMID: 26002288

3

Up-regulation of CYLD enhances Listeria monocytogenes induced apoptosis in THP-1 cells.

Xu C, Yang L, Yuan Y, Du F, Wang S, Wang X, Zhu L, Zhang B, Weaver D. Xu C, et al. Microb Pathog. 2016 Jan;90:50-4. doi: 10.1016/j.micpath.2015.10.007. Epub 2015 Nov 3. Microb Pathog. 2016. PMID: 26545866

4

Inactivation of deubiquitinase CYLD enhances therapeutic antibody production in Chinese hamster ovary cells.

Lu Y, Zhou Q, Han Q, Wu P, Zhang L, Zhu L, Weaver DT, Xu C, Zhang B. Lu Y, et al. Among authors: xu c. Appl Microbiol Biotechnol. 2018 Jul;102(14):6081-6093. doi: 10.1007/s00253-018-9070-x. Epub 2018 May 15. Appl Microbiol Biotechnol. 2018. PMID: 29766242

5

MiR-106b promotes therapeutic antibody expression in CHO cells by targeting deubiquitinase CYLD.

Xu C, Han Q, Zhou Q, Zhang L, Wu P, Lu Y, Si Y, Ma T, Ma B, Zhang B. Xu C, et al. Appl Microbiol Biotechnol. 2019 Sep;103(17):7085-7095. doi: 10.1007/s00253-019-10000-3. Epub 2019 Jul 10. Appl Microbiol Biotechnol. 2019. PMID: 31292678

6

Stable overexpression of mutated PTEN in Chinese hamster ovary cells enhances their performance and therapeutic antibody production.

Zhou Q, Zhang Y, Lu X, Wang C, Pei X, Lu Y, Cao C, Xu C, Zhang B. Zhou Q, et al. Among authors: xu c. Biotechnol J. 2021 Sep;16(9):e2000623. doi: 10.1002/biot.202000623. Epub 2021 Jun 19. Biotechnol J. 2021. PMID: 34053183

7

An Anti-EGFR/anti- HER2 Bispecific Antibody with Enhanced Antitumor Activity Against Acquired Gefitinib-Resistant NSCLC Cells.

Si Y, Pei X, Wang X, Han Q, Xu C, Zhang B. Si Y, et al. Among authors: xu c. Protein Pept Lett. 2021;28(11):1290-1297. doi: 10.2174/0929866528666210930170624. Protein Pept Lett. 2021. PMID: 34602035

8

BRD4 Targets the KEAP1-Nrf2-G6PD Axis and Suppresses Redox Metabolism in Small Cell Lung Cancer.

Lv Y, Lv X, Zhang J, Cao G, Xu C, Zhang B, Lin W. Lv Y, et al. Among authors: xu c. Antioxidants (Basel). 2022 Mar 29;11(4):661. doi: 10.3390/antiox11040661. Antioxidants (Basel). 2022. PMID: 35453346 Free PMC article.

9

Sheep tail fat inhibits the proliferation of non-small-cell lung cancer cells in vitro and in vivo.

Xu C, Zhang L, He H, Liu X, Pei X, Ma T, Ma B, Lin W, Zhang B. Xu C, et al. Front Pharmacol. 2022 Aug 11;13:917513. doi: 10.3389/fphar.2022.917513. eCollection 2022. Front Pharmacol. 2022. PMID: 36034869 Free PMC article.

10

High-efficiency genetic engineering toolkit for virus based on lambda red-mediated recombination.

Yi J, Zhang M, Zhu L, Xu C, Li B, Wu P, Wu H, Zhang B. Yi J, et al. Among authors: xu c. Biotechnol Lett. 2023 Oct;45(10):1327-1337. doi: 10.1007/s10529-023-03412-9. Epub 2023 Aug 1. Biotechnol Lett. 2023. PMID: 37526868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,086 results

Search Page

Filters